Literature DB >> 23928469

ATM is required for the repair of Topotecan-induced replication-associated double-strand breaks.

Sabrina Köcher1, Anja Spies-Naumann, Malte Kriegs, Jochen Dahm-Daphi, Irena Dornreiter.   

Abstract

PURPOSE: DNA replication is a promising target for anti-cancer therapies. Therefore, the understanding of replication-associated DNA repair mechanisms is of great interest. One key factor of DNA double-strand break (DSB) repair is the PIK kinase Ataxia-Telangiectasia Mutated (ATM) but it is still unclear whether ATM is involved in the repair of replication-associated DSBs. Here, we focused on the involvement of ATM in homology-directed repair (HDR) of indirect DSBs associated with replication.
MATERIAL AND METHODS: Experiments were performed using ATM-deficient and -proficient human cells. Replication-associated DSBs were induced with Topotecan (TPT) and compared with γ-irradiation (IR). Cell survival was measured by clonogenic assay. Overall DSB repair and HDR were evaluated by detecting residual γH2AX/53BP1 and Rad51 foci, respectively. Cell cycle distribution was analysed by flow cytometry and protein expression by Western blot.
RESULTS: ATM-deficiency leads to enhanced numbers of residual DSBs, resulting in a pronounced S/G2-block and decreased survival upon TPT-treatment. In common with IR, persisting Rad51 foci were detected following TPT-treatment.
CONCLUSIONS: These results demonstrate that ATM is essentially required for the completion of HR-mediated repair of TPT-induced DSBs formed indirectly at replication forks.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  ATM; Homology-directed repair; Replication-associated DSBs; SKX; Topotecan

Mesh:

Substances:

Year:  2013        PMID: 23928469     DOI: 10.1016/j.radonc.2013.06.024

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  8 in total

1.  Flavone protects HBE cells from DNA double-strand breaks caused by PM2.5.

Authors:  Xing Ren; Yong Tang; Jiameng Sun; Jianbo Feng; Leilei Chen; Huixi Chen; Sijing Zeng; Changhui Chen; Xinqiu Li; Haixia Zhu; Zhaojun Zeng
Journal:  Hum Cell       Date:  2017-11-22       Impact factor: 4.174

Review 2.  Topoisomerase-mediated chromosomal break repair: an emerging player in many games.

Authors:  Mohamed E Ashour; Reham Atteya; Sherif F El-Khamisy
Journal:  Nat Rev Cancer       Date:  2015-02-19       Impact factor: 60.716

3.  FL118 induces p53-dependent senescence in colorectal cancer cells by promoting degradation of MdmX.

Authors:  Xiang Ling; Chao Xu; Chuandong Fan; Kai Zhong; Fengzhi Li; Xinjiang Wang
Journal:  Cancer Res       Date:  2014-12-15       Impact factor: 12.701

4.  Defects in DNA Repair Genes Predict Response to Neoadjuvant Cisplatin-based Chemotherapy in Muscle-invasive Bladder Cancer.

Authors:  Elizabeth R Plimack; Roland L Dunbrack; Timothy A Brennan; Mark D Andrake; Yan Zhou; Ilya G Serebriiskii; Michael Slifker; Katherine Alpaugh; Essel Dulaimi; Norma Palma; Jean Hoffman-Censits; Marijo Bilusic; Yu-Ning Wong; Alexander Kutikov; Rosalia Viterbo; Richard E Greenberg; David Y T Chen; Costas D Lallas; Edouard J Trabulsi; Roman Yelensky; David J McConkey; Vincent A Miller; Erica A Golemis; Eric A Ross
Journal:  Eur Urol       Date:  2015-08-01       Impact factor: 20.096

5.  The Topoisomerase 1 Inhibitor Austrobailignan-1 Isolated from Koelreuteria henryi Induces a G2/M-Phase Arrest and Cell Death Independently of p53 in Non-Small Cell Lung Cancer Cells.

Authors:  Chun-Chi Wu; Keh-Feng Huang; Tsung-Ying Yang; Ya-Ling Li; Chi-Luan Wen; Shih-Lan Hsu; Tzu-Hsiu Chen
Journal:  PLoS One       Date:  2015-07-06       Impact factor: 3.240

6.  Involvement of ATM in homologous recombination after end resection and RAD51 nucleofilament formation.

Authors:  A Bakr; C Oing; S Köcher; K Borgmann; I Dornreiter; C Petersen; E Dikomey; W Y Mansour
Journal:  Nucleic Acids Res       Date:  2015-03-09       Impact factor: 16.971

7.  Evaluation of ATM Kinase Inhibitor KU-55933 as Potential Anti-Toxoplasma gondii Agent.

Authors:  Jonathan Munera López; Agustina Ganuza; Silvina S Bogado; Daniela Muñoz; Diego M Ruiz; William J Sullivan; Laura Vanagas; Sergio O Angel
Journal:  Front Cell Infect Microbiol       Date:  2019-02-13       Impact factor: 5.293

8.  A small molecule inhibitor of human RAD51 potentiates breast cancer cell killing by therapeutic agents in mouse xenografts.

Authors:  Fei Huang; Alexander V Mazin
Journal:  PLoS One       Date:  2014-06-27       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.